ÂÜÀòÂÒÂ×

Regis A. Vilchez, MD, PhD, currently serves as Chief Medical Officer at MicuRx Pharmaceuticals, Inc., leading global R&D activities to identify new treatments and drug targets. Vilchez has extensive experience in clinical development, previously holding advisory and leadership positions at BiomX Inc. and BiomX Inc. as Senior Vice President of Clinical Development, focusing on phage therapies. Prior consulting engagements include being an Independent Biotechnology Consultant at VILBO LifeSciences, Inc., and significant roles at Mallinckrodt Pharmaceuticals, where Vilchez developed multidisciplinary clinical and translational strategies across various therapeutic areas. Academic involvement includes serving as Adjunct Research Faculty at Baylor College of Medicine, with a focus on virology. Vilchez's prestigious educational background includes a PhD in Clinical Investigation/Virology from Baylor College of Medicine and extensive fellowship training in infectious diseases.